| |
N
|
ASP
|
LBP
|
CPC
|
MIX
|
|---|
|
Body weight (g/d)
|
|
Week 0
|
229 ± 2
|
232 ± 2
|
231 ± 2
|
234 ± 2
|
233 ± 2
|
|
Week 1
|
305 ± 2
|
305 ± 2
|
307 ± 1
|
308 ± 3
|
310 ± 3
|
|
Week 9
|
427 ± 7
|
344 ± 11*
|
368 ± 7*
|
352 ± 11*
|
351 ± 8*
|
|
Weight gain (g)
|
197.3 ± 6.9
|
111.9 ± 11.1*
|
137.6 ± 7.1*
|
117.4 ± 11.1*
|
118.5 ± 8.4*
|
|
Food intake (g/d)
|
|
Pre-treatment (week 1)
|
29.4 ± 0.3
|
29.4 ± 0.5
|
30.5 ± 0.2
|
30.2 ± 0.2
|
29.9 ± 0.2
|
|
Induction (weeks 2–9)
|
21.9 ± 0.3
|
18.5 ± 0.5*
|
19.8 ± 0.2*#
|
18.9 ± 0.4*
|
18.5 ± 0.4*
|
|
Aspirin intake (mg/kg bw/d)
|
–
|
587 ± 16
|
628 ± 8#
|
601 ± 13
|
590 ± 14
|
|
Completion rate (%)
|
–
|
84 ± 2
|
90 ± 1#
|
86 ± 2
|
84 ± 2
|
- Data are mean ± SEM (n = 10–12 per group). Differences between the groups were determined by one-way ANOVA followed by Fisher’s least significant difference test
- N, standard powder diet; ASP, aspirin; LBP, aspirin + Lycium barbarum polysaccharides (LBP); CPC, aspirin + C-phycocyanin (CPC); MIX, aspirin + LBP + CPC
- *p < 0.05 compared with the N group; #p < 0.05 compared with the ASP group
